Dietary recommendations for pediatric and adolescent patients utilizing GLP‐1 receptor agonists for weight management: A narrative review of current literature

Glucagon‐like peptide‐1 (GLP‐1) receptor agonists are becoming an increasingly important tool in addressing obesity in the US, with burgeoning use in pediatric and adolescent populations. Although their use is expanding, there is a notable gap in the literature regarding optimal dietary guidelines for these patients. This review synthesizes current evidence on dietary recommendations for patients using GLP‐1 receptor agonists for weight management, with particular emphasis on strategies for pediatric and adolescent populations. Key strategies include prioritizing protein in the diet to help maintain lean body mass, gradually increasing fiber content to minimize gastrointestinal side effects, focusing on nutrient‐dense meals in smaller, more frequent portions, and monitoring micronutrients to prevent deficiencies. Successful implementation of these dietary guidelines relies on an interdisciplinary approach to optimize both short‐ and long‐term success.